具有偏向IL2受体结合用于癌症免疫治疗的特定位点的基化IL2蛋白
Bei Tong1, Sirou Grace Leong2, Tunyu Jian1
1Jiangsu Key Laboratory for the Research and Utilization of Plant Resources, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, China.
International immunopharmacology
|May 30, 2024
概括
一种新型的Interleukin 2 (IL2) 变体,IL2-4M-PEG,通过增强效应细胞并降低毒性来增强抗瘤免疫力. 这种修改后的IL2显示出改善癌症疗法的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 癌症治疗 癌症治疗
背景情况:
- 互白素2 (IL2) 有效地激活NK和T细胞,但面临着短半衰期,毒性和Treg细胞诱导等挑战.
- 这些局限性阻碍了IL2在癌症治疗中的广泛应用.
研究的目的:
- 设计一种具有改善治疗特性的新型IL2变体 (IL2-4M-PEG).
- 为了降低IL2的CD25结合活性,并延长其体内半衰期.
主要方法:
- 进行了氨基酸替代,以减少CD25结合.
- 用于延长IL2变种的半衰期,采用了位点导向的PEGylation.
- 工程IL2变体对免疫细胞和抗瘤活性的影响在小鼠模型中进行了评估.
主要成果:
- 这种IL2-4M-PEG变体显示了减少CD25结合和延长半衰期.
- 优选IL2-4M-PEG放大效应细胞 (NK和T细胞),而不是调节性T (Treg) 细胞.
- 工程 IL2 变体在体内表现出显著的抗瘤作用.
结论:
- 新的IL2-4M-PEG变异为克服IL2在癌症治疗中的局限性提供了一个有希望的方法.
- 这种修改后的IL2有可能提高组合癌症治疗的疗效.
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K